← Organizations
Sponsor / Institution
Massachusetts Eye and Ear Infirmary
Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.
Programs
2
linked to organization
Strong Evidence
0
0 status confirmed
Details Checked
2
0 open data checks
Company / Institution Links
0 / 2
industry vs non-industry records
Competitive Density
6
Pipeline Velocity
50
Completion Signal
50
Programs by Stage
Phase 11
Phase 31
Trial / Program Status
Active1
Completed1
Modality Mix
Diagnostic1
Steroid/Anti-inflammatory1
Indication Coverage
Hearing Loss2
Sensorineural Hearing Loss1
Sudden Sensorineural Hearing Loss1
Tinnitus1
Program Types
Diagnostic1
Therapeutic1
Population Tags
adult2
hearing-loss1
neuroimaging1
normal-hearing-control1
sensorineural1
sudden1
tinnitus1
unilateral1
Strong-Evidence Records
0 recordsNo strong-evidence records are linked to this organization yet.
Checked Records With Caveats
2 checked · 0 open checksMEEI sudden deafness steroid treatment trial
Details checked
Steroid/Anti-inflammatoryPhase 3Completed
Completed multicenter Phase 3 non-inferiority trial comparing intratympanic methylprednisolone sodium succinate injections with oral prednisone for idiopathic sudden sensorineural hearing loss.
Data checks: institution-led-study, published-results
Mass Eye and Ear IV lidocaine fMRI tinnitus study
Details checked
DiagnosticPhase 1Active
Open-label pharmacologic fMRI challenge study comparing tinnitus-related brain activity before and after IV lidocaine infusion; the purpose is diagnostic/neuroimaging signal discovery rather than development of a tinnitus drug product.
Data checks: investigator-led-study, diagnostic-study-not-therapeutic-product